back
09 Mar 2022

DPI CDC announce KELIX bio agreement to acquire PHI $200m second funding round

https://www.dpi-llp.com/wp-content/uploads/2022/03/DPI-CDC-announce-KELIX-bio-agreement-to-acquire-PHI-200m-second-funding-round_vfinal.pdf

Related articles

Kazyon attracts $165 million investment from DPI-led consortium
| 27 Apr 2023
DPI-led consortium to buy Solevo, a leading African distributor of specialty chemicals from Helios
| 19 Apr 2023
Marcyrl attracts new investment from DPI and Amethis
| 06 Apr 2023
See all news
Copyright © DPI 2023